What’s scary, and appealing, about real-world evidence
The idea of real-world evidence is energizing much of the health world. For the rest, it's terrifying.
Last week STAT senior writer Matthew Herper wrote a story about a collaboration between Flatiron Health and the Food and Drug Administration, and a vexing topic called real-world evidence, which basically means the integration of types of data beyond clinical trials into the drug approval process. (You can read that story here.)
On Tuesday, Herper held a . Here is an edited partial transcript (emphasis on partial — subscribers got to go ) on the topic, particularly the area of “synthetic controls,” which Herper called “the biggest idea, the most appealing, and the scariest.”
